间歇性跛行患者血运重建与慢性肢体威胁性缺血及截肢风险增加相关
单中心回顾性研究纳入1051例初始诊断为间歇性跛行的患者,比较血运重建与否对进展为慢性肢体威胁性缺血(CLTI)和截肢的影响。多变量Cox回归显示,血运重建与进展为CLTI(HR 2.9,95%CI 2.0-4.2)和截肢(HR 4.5,95%CI 2.2-9.5)显著相关,倾向性匹配队列亦证实此结果。
要点
- 间歇性跛行患者血运重建与CLTI进展风险增加相关(HR 2.9)。
- 血运重建与截肢风险增加相关(HR 4.5)。
- 需进一步研究明确哪些间歇性跛行患者能从血运重建中获益。
核心结论
- 间歇性跛行患者血运重建与进展为CLTI和截肢率增加相关。
研究设计与样本
- 单中心回顾性研究,纳入2003年6月11日至2019年4月24日初始诊断为间歇性跛行的1051例患者。
主要发现
- 多变量Cox回归显示血运重建与进展为CLTI显著相关(HR 2.9;95%CI 2.0-4.2)。
- 多变量Cox回归显示血运重建与截肢显著相关(HR 4.5;95%CI 2.2-9.5)。
- 倾向性匹配队列(218例血运重建 vs 340例非血运重建)亦证实上述结果。
临床怎么用
- 对间歇性跛行患者应谨慎评估血运重建指征,优先考虑戒烟、监督运动疗法和最佳药物治疗。
局限性
- 单中心回顾性研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is an increasing incidence of peripheral arterial disease (PAD). The most common symptomatic presentation of PAD is intermittent claudication (IC), reproducible leg pain with ambulation. The progression of symptoms beyond IC is rare, and a nonprocedural approach of smoking cessation, supervised exercise therapy, and best medical therapy can mitigate progression of IC. Despite the lack of limb- or life-threatening sequelae of IC, invasive treatment strategies of IC have experienced rapid growth. Within our health care system, PAD is treated by multiple disciplines with varying practice patterns, providing an opportunity to investigate the progression of IC based on treatment strategy. This study aims to compare PAD progression and amputation in patients with IC with and without revascularization. METHODS: This institutional review board-approved, single institute retrospective study reviewed all patients with an initial diagnosis of IC between June 11, 2003, and April 24, 2019. Revascularization was defined as endovascular or open. Time to chronic limb-threatening ischemia (CLTI) diagnosis and amputation were stratified by revascularization status using the Kaplan-Meier method. The association between revascularization status and each of CLTI progression and amputation using multivariable Cox regression, adjusting for demographic and clinical potential confounding variables was assessed. RESULTS: We identified 1051 patients who met the inclusion criteria. Of these patients, 328 had at least one revascularization procedure and 723 did not. The revascularized group was younger than the nonrevascularized group (60.3 years vs 62.1 years; P = .013). There was no significant difference in sex or comorbidities in the two groups other than a higher rate of diabetes mellitus type 2 (32.3% vs 16.3%; P < .001) and COPD (4.3% vs 1.7%; P = .017) in the revascularized group. Multivariable Cox regression found revascularization of patients with IC to be significantly associated with the progression to CLTI (hazard ratio, 2.9; 95% confidence interval, 2.0-4.2) and amputation (hazard ratio, 4.5; 95% confidence interval, 2.2-9.5). These findings were also demonstrated in propensity-matched cohorts of 218 revascularized and 340 nonrevascularized patients. CONCLUSIONS: Revascularization of patients with IC is associated with an increased rate of progression to CLTI and increased amputation rates. Given these findings, further studies are required to identify which, if any, patients with IC benefit from revascularization procedures.
引用
- Madabhushi V, Davenport D, Jones S, et al. Revascularization of intermittent claudicants leads to more chronic limb-threatening ischemia and higher amputation rates. J Vasc Surg. 2021. PMID: 33775749. doi:10.1016/j.jvs.2021.02.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。